Dotan, A., Ben-Shabat, N., Mcgonagle, D., Amital, H., & Watad, A. (2023). POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS. Annals of the rheumatic diseases, 82(Suppl 1), 1148-1149. https://doi.org/10.1136/annrheumdis-2023-eular.4556
Citácia podle Chicago (17th ed.)Dotan, A., N. Ben-Shabat, D. Mcgonagle, H. Amital, a A. Watad. "POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 82, no. Suppl 1 (2023): 1148-1149. https://doi.org/10.1136/annrheumdis-2023-eular.4556.
Citácia podľa MLA (8th ed.)Dotan, A., et al. "POS1607 BIOLOGICS THERAPIES FOR PSORIASIS DECREASE FUTURE RISK FOR DEVELOPING PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases, vol. 82, no. Suppl 1, 2023, pp. 1148-1149, https://doi.org/10.1136/annrheumdis-2023-eular.4556.